PINK1 mutation heterozygosity and the risk of Parkinson's disease

Por Toft, M, Myhre, R, Pielsticker, L, White, L R, Aasly, J O, Farrer, M J
Publicado em 2007

Lrrk2 Localization in the Primate Basal ganglia and Thalamus: A Light and Electron Microscopic Analysis in Monkeys

Por Lee, H., Melrose, H.L., Yu, M., Pare, Jean-Francois, Farrer, M.J., Smith, Y.
Publicado em 2010

Meiotic crossing-over in nondisjoined chromosomes of children with trisomy 21 and a congenital heart defect.

Por Howard, C M, Davies, G E, Farrer, M J, Cullen, L M, Coleman, M M, Williamson, R, Wyse, R K, Palmer, R, Kessling, A M
Publicado em 1993

Progression of dopaminergic dysfunction in a LRRK2 kindred: A multitracer PET study

Por Nandhagopal, R, Mak, E, Schulzer, M, McKenzie, J, McCormick, S, Sossi, V, Ruth, T J., Strongosky, A, Farrer, M J., Wszolek, Z K., Stoessl, A J.
Publicado em 2008

MEIS1 p.R272H IN FAMILIAL RESTLESS LEGS SYNDROME

Por Vilariño-Güell, C, Chai, H, Keeling, B H., Young, J E., Rajput, A, Lynch, T, Aasly, J O., Uitti, R J., Wszolek, Z K., Farrer, M J., Lin, S -C.
Publicado em 2009

MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy

Por Vilariño-Güell, C., Soto-Ortolaza, A.I., Rajput, A., Mash, D.C., Papapetropoulos, S., Pahwa, R., Lyons, K.E., Uitti, R.J., Wszolek, Z.K., Dickson, D.W., Farrer, M.J., Ross, O.A.
Publicado em 2011

A family with parkinsonism, essential tremor, restless legs syndrome, and depression

Por Puschmann, A., Pfeiffer, R.F., Stoessl, A.J., Kuriakose, R., Lash, J.L., Searcy, J.A., Strongosky, A.J., Vilariño-Güell, C., Farrer, M.J., Ross, O.A., Dickson, D.W., Wszolek, Z.K.
Publicado em 2011

Association of the MAPT locus with Parkinson’s disease

Por Wider, C., Vilariño-Güell, C., Jasinska-Myga, B., Heckman, M. G., Soto-Ortolaza, A. I., Cobb, S. A., Aasly, J. O., Gibson, J. M., Lynch, T., Uitti, R. J., Wszolek, Z. K., Farrer, M. J., Ross, O. A.
Publicado em 2009

AN INDEPENDENT REPLICATION OF PARK16 IN ASIAN SAMPLES

Por Vilariño-Güell, C., Ross, O.A., Aasly, J.O., White, L.R., Rajput, A., Rajput, A.H., Lynch, T., Krygowska-Wajs, A., Jasinska-Myga, B., Opala, G., Barcikowska, M., Lee, M.-C., Hentati, F., Uitti, R.J., Wszolek, Z.K., Farrer, M.J., Wu, R.-M.
Publicado em 2010

Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1 redefining DYT14 as DYT5

Por Wider, C., Melquist, S., Hauf, M., Solida, A., Cobb, S.A., Kachergus, J.M., Gass, J., Coon, K.D., Baker, M., Cannon, A., Stephan, D.A., Schorderet, D.F., Ghika, J., Burkhard, P.R., Kapatos, G., Hutton, M., Farrer, M.J., Wszolek, Z.K., Vingerhoets, F.J.G.
Publicado em 2007

PINK1 mutations and parkinsonism

Por Ishihara-Paul, L, Hulihan, M M., Kachergus, J, Upmanyu, R, Warren, L, Amouri, R, Elango, R, Prinjha, R K., Soto, A, Kefi, M, Zouari, M, Sassi, S B., Yahmed, S B., El Euch-Fayeche, G, Matthews, P M., Middleton, L T., Gibson, R A., Hentati, F, Farrer, M J.
Publicado em 2008

Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice

Por Melrose, H. L., Dächsel, J. C., Behrouz, B., Lincoln, S. J., Yue, M., Hinkle, K. M., Kent, C., Korvatska, E., Taylor, J. P., Witten, L., Liang, Y-Q, Beevers, J. E., Boules, M., Serna, V., Gaukhman, A., Yu, X., Castanedes-Casey, M., Braithwaite, A. T., Ogholikhan, S., Yu, N., Bass, D., Tyndall, G., Schellenberg, G. D., Dickson, D. W., Janus, C., Farrer, M. J.
Publicado em 2010

Characterization of DCTN1 genetic variability in neurodegeneration

Por Vilariño-Güell, C, Wider, C, Soto-Ortolaza, A I., Cobb, S A., Kachergus, J M., Keeling, B H., Dachsel, J C., Hulihan, M M., Dickson, D W., Wszolek, Z K., Uitti, R J., Graff-Radford, N R., Boeve, B F., Josephs, K A., Miller, B, Boylan, K B., Gwinn, K, Adler, C H., Aasly, J O., Hentati, F, Destée, A, Krygowska-Wajs, A, Chartier-Harlin, M -C., Ross, O A., Rademakers, R, Farrer, M J.
Publicado em 2009

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease

Por Haugarvoll, K., Rademakers, R., Kachergus, J.M., Nuytemans, K., Ross, O.A., Gibson, J.M., Tan, E.-K., Gaig, C., Tolosa, E., Goldwurm, S., Guidi, M., Riboldazzi, G., Brown, L., Walter, U., Benecke, R., Berg, D., Gasser, T., Theuns, J., Pals, P., Cras, P., De Deyn, P. Paul, Engelborghs, S., Pickut, B., Uitti, R.J., Foroud, T., Nichols, W.C., Hagenah, J., Klein, C., Samii, A., Zabetian, C.P., Bonifati, V., Van Broeckhoven, C., Farrer, M.J., Wszolek, Z.K.
Publicado em 2008

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson’s disease: analysis of a large multi-center study

Por Wang, L., Heckman, M.G., Aasly, J. O., Annesi, G., Bozi, M., Chung, S. J., Clarke, C., Crosiers, D., Eckstein, G., Garraux, G., Hadjigeorgiou, G. M., Hattori, N., Jeon, B., Kim, Y. J., Kubo, M., Lesage, S., Lin, J. J., Lynch, T., Lichtner, P., Mellick, G. D., Mok, V., Morrison, K. E., Quattrone, A., Satake, W., Silburn, P. A., Stefanis, L., Stockton, J. D., Tan, E. K., Toda, T., Brice, A., Van Broeckhoven, C., Uitti, R. J., Wirdefeldt, K., Wszolek, Z., Xiromerisiou, G., Maraganore, D. M., Gasser, T., Kruger, R., Farrer, M. J., Ross, O. A., Sharma, M.
Publicado no Neurobiol Aging (2016)